BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Ovulation Test Kit Market: Increase in Fertility Rates across the Globe is Expected to Drive the Market

  The global ovulation test kit market is expected to gain immense momentum in the forecast period on account of the increase in fertility rates across the globe.

  December 7, 2020

   · 

  4 min read
• New abstracts on the use of Blue Light Cystoscopy with Cysview presented at SUO

  Photocure ASA announced new data and analyses presented at the 21st Annual Meeting of the Society of Urologic Oncology.

  December 7, 2020

   · 

  6 min read
• Pharm Country

  The world’s first DNA “tricorder” in your pocket

  Cold Spring Harbor Laboratory scientists developed the world’s first mobile genome sequence analyzer, a new iPhone app called iGenomics.

  December 7, 2020

   · 

  2 min read
• Drug Development

  HOOKIPA Interim Phase 1 Monotherapy Data of HB-201 for the Treatment of Advanced HPV16+ Cancers Shows Promising Anti-Tumor Activity and Favorable Tolerability

  Data demonstrate responses and stable disease in some head and neck cancer patients who all received at least two prior therapies and progressed on a PD1 inhibitor

  December 7, 2020

   · 

  9 min read
• Pharm Country

  Matinas BioPharma Announces Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate Oral Formulations of Gilead’s Antiviral Remdesivir Utilizing Matinas’ LNC Platform Delivery Technology

  Matinas BioPharma Holdings, Inc. announced that they plan to collaborate with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to test oral formulations of remdesivir in preclinical models.

  December 7, 2020

   · 

  6 min read
• Tetra Bio-Pharma Provides Update on Market Potential for QIXLEEF(TM)

  Tetra Bio-Pharma Inc., a leader in cannabinoid-derived drug discovery and development, provided an update on the potential US market for QIXLEEF™, a botanical cannabinoid-derived medicine that meets USA cGMP regulatory requirements.

  December 7, 2020

   · 

  5 min read
• Lexaria to Highlight its DehydraTECHTM Technology at Four Upcoming Investor Conferences

  Lexaria Bioscience Corp., a global innovator in drug delivery platforms, announced that its Chairman & CEO Chris Bunka is scheduled to present at four upcoming investor conferences in December 2020 and January 2021.

  December 7, 2020

   · 

  5 min read
• Sequana Medical to Host KOL Event on “The Challenge of Diuretic Resistance in the Management of Heart Failure Patients and the Potential for alfapump® DSR therapy”

  Sequana Medical NV announces that it will hold a key opinion leader event on the challenge of diuretic resistance in the management of heart failure patients and the potential for alfapump® DSR therapy, on Friday 11 December 2020 at 03:00 pm CET / 09:00 am EST.

  December 7, 2020

   · 

  7 min read
• Blood Plasma Market: Increased Prevalence of Cases of Hemophilia to Support Growth of the Market

  Blood plasma refers to the liquid part of the blood. It is a versatile element and it comprises around 55% of the blood.

  December 7, 2020

   · 

  3 min read
• AI in Diagnostic Imaging Market: Higher Appropriation of Cutting Edge Clinical Imaging Innovations to Drive the Market

  AI in diagnostic imaging is gaining prominence and quickly growing industry close to what’s to come.

  December 7, 2020

   · 

  5 min read